Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
EVBox Group to Become Public Company via Business Combination with TPG Pace Beneficial Finance (TPGY)
-
EVBox Group to Become Public Company via Business Combination with TPG Pace Beneficial Finance
-
Cityblock Health Raises $160M Series C to Address Systemic Healthcare Inequity
-
Form SC 13G/A TANDEM DIABETES CARE Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Syndax Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A GLYCOMIMETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program
-
Wellington Management Announces Close of Wellington Hadley Harbor III at US$1.8 Billion
-
BayBoston Announces Hiring of Andres SaldaƱa as General Counsel and the Retirement of Richard Toomey
-
Current Announces $131 Million in Series C funding; Surpasses 2 Million Members
-
Verve Therapeutics to Present at the Piper Sandler Annual Virtual Healthcare Conference
-
Butterfly Network to be listed on NYSE through merger with Longview Acquisition Corp. (LGVW)
-
Butterfly Network, a global leader in democratizing medical imaging, to be listed on NYSE through a merger with Longview Acquisition Corp.
-
UNCF Launches Wellington Management Foundation Scholarship Program
-
Arrival, the company creating electric vehicles with its game-changing technologies, to list on NASDAQ through merger with CIIG Merger Corp.
-
Arrival, the company creating electric vehicles with its game-changing technologies, to list on NASDAQ through merger with CIIG Merger Corp.
-
Morgan Stanley Launches the Institute for Inclusion
-
Arrival to list on NASDAQ through merger with CIIG Merger Corp. (CIIC)
-
Form 13F-HR WELLINGTON MANAGEMENT For: Sep 30
-
Vontobel Asset Management Strengthens Its Institutional Distribution in Key US Territory
-
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
-
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
-
What Are Good Penny Stocks To Buy Right Now? 4 For Your Watch List?
-
miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
-
Form SC 13G StepStone Group Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A MultiPlan Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G ChemoCentryx, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A MyoKardia, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Cinemark Holdings, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ADVANCED DRAINAGE SYSTEM Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Akebia Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Triton International Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Iterum Therapeutics plc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Verve Therapeutics Announces Presentations on its Gene Editing Approach to Develop Transformative Medicines for Coronary Heart Disease at the American Heart Association Scientific Sessions 2020
-
BGL Announces the Merger of Lordstown Motors Corporation with DiamondPeak Holdings Corporation in a Transaction Valued Over $1.6 Billion
-
LianBio Announces $310 Million Crossover Financing
-
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies
-
Mobile game startup Scopely raises $340 million
-
Scopely Continues Rapid Growth in Competitive Mobile Games Space with $340M Series E
-
miRagen Therapeutics (MGEN) Announces Acquisition of Viridian Therapeutics
-
miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.
-
Ares Management Appoints Raj Krishnan as Partner and Chief Investment Officer of Ares Insurance Solutions
-
Northern Trust Adds to Foundation & Institutional Advisors Practice in Chicago
-
Nuvation Bio and Panacea Announce Business Combination Agreement, Creating a Publicly Listed Leader in Oncology Drug Development
-
Gemini Therapeutics and FS Development Corp. Announce Merger Agreement Creating Publicly Listed Precision Medicine Company Focused on Age-Related Macular Degeneration
-
Form SC 13G/A PINTEREST, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Satsuma Pharmaceuticals, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Hill-Rom Holdings, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Olema Oncology Raises $85 Million in Series C Financing to Advance Clinical Development of OP-1250 in Breast Cancer

